PlainRecalls
FDA Drug Critical Class I Terminated

Levofloxacin in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), 50 mL Single-Use flexible container, Rx Only, Manufactured for: AuroMedics Pharma LLC 6 Wheeling Drive, Dayton, NJ 08810 Manufactured for: Aurobindo Pharma Limited IDA, Pashamylaram - 502307, India ---- NDC 55150-243-46

Reported: March 7, 2018 Initiated: January 12, 2018 #D-0574-2018

Product Description

Levofloxacin in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), 50 mL Single-Use flexible container, Rx Only, Manufactured for: AuroMedics Pharma LLC 6 Wheeling Drive, Dayton, NJ 08810 Manufactured for: Aurobindo Pharma Limited IDA, Pashamylaram - 502307, India ---- NDC 55150-243-46

Reason for Recall

Presence of Particulate Matter; contains visible particulate matter identified as mold.

Details

Recalling Firm
AuroMedics Pharma LLC
Units Affected
6,072 bags
Distribution
Nationwide
Location
East Windsor, NJ

Frequently Asked Questions

What product was recalled?
Levofloxacin in 5% Dextrose Injection, 250 mg/50 mL (5 mg/mL), 50 mL Single-Use flexible container, Rx Only, Manufactured for: AuroMedics Pharma LLC 6 Wheeling Drive, Dayton, NJ 08810 Manufactured for: Aurobindo Pharma Limited IDA, Pashamylaram - 502307, India ---- NDC 55150-243-46. Recalled by AuroMedics Pharma LLC. Units affected: 6,072 bags.
Why was this product recalled?
Presence of Particulate Matter; contains visible particulate matter identified as mold.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 7, 2018. Severity: Critical. Recall number: D-0574-2018.